Towa Pharmaceutical Co., Ltd. (TYO:4553)

Market Cap	153.83B
Revenue (ttm)	259.59B
Net Income (ttm)	18.99B
Shares Out	49.23M
EPS (ttm)	385.70
PE Ratio	8.10
Forward PE	8.77
Dividend	80.00 (2.56%)
Ex-Dividend Date	Mar 28, 2025

Volume	47,400
Average Volume	186,115
Open	3,155.00
Previous Close	3,125.00
Day's Range	3,090.00 - 3,155.00
52-Week Range	2,298.00 - 3,395.00
Beta	-0.17
RSI	63.26
Earnings Date	May 15, 2025

About Towa Pharmaceutical

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It also offers IT service related to healthcare; and disease risk testing services. In addition, the company is involved with research and development of diagnostic drugs; and planning, devel...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1951
• Employees: 4,588
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4553

Financial Performance

In 2024, Towa Pharmaceutical's revenue was 259.59 billion, an increase of 13.89% compared to the previous year's 227.93 billion. Earnings were 18.99 billion, an increase of 17.39%.